FDA Inspection
Sagent PharmaceuticalsSagent Pharmaceuticals – FDA Inspection, Mar 31, 2010
Record Details
This FDA Inspection record concerns Sagent Pharmaceuticals, with an inspection on March 31, 2010, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Sagent Pharmaceuticals
- Inspection Date
- March 31, 2010
- Product Type
- Drugs
View Company Profile
ID · 0adbba33-2112-4b8f-b825-4db350e9f4b5
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 655430
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Sagent Pharmaceuticals
6| Date | Classification | Office | Project area |
|---|---|---|---|
| September 20, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| December 18, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 24, 2018 | VAI | Center for Drug Evaluation and Research | Postmarket Surv. and Epidemiology |
| August 19, 2015 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| May 11, 2012 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Sagent Pharmaceuticals
- FDA Inspection 1231342 - 2024-09-20
- FDA Inspection 1114257 - 2019-12-18
- FDA Inspection 1066792 - 2018-09-24
- FDA Inspection 940865 - 2015-08-19
- FDA Inspection 782558 - 2012-05-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.